TXK
MOLECULAR TARGETTXK tyrosine kinase
TXK (TXK tyrosine kinase) is targeted by 27 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting TXK
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | gefitinib | 5.67 | 290 |
| 2 | erlotinib | 5.55 | 256 |
| 3 | sb 203580 | 4.92 | 136 |
| 4 | ibrutinib | 4.86 | 128 |
| 5 | foretinib | 4.34 | 76 |
| 6 | tozasertib | 4.33 | 75 |
| 7 | vandetanib | 4.30 | 73 |
| 8 | bosutinib | 4.08 | 58 |
| 9 | pazopanib | 3.69 | 39 |
| 10 | neratinib | 3.66 | 38 |
| 11 | nintedanib | 3.61 | 36 |
| 12 | canertinib | 3.53 | 33 |
| 13 | pelitinib | 3.50 | 32 |
| 14 | tae 684 | 3.43 | 30 |
| 15 | fedratinib | 3.40 | 29 |
| 16 | acalabrutinib | 3.22 | 24 |
| 17 | lestaurtinib | 3.04 | 20 |
| 18 | spebrutinib | 3.04 | 20 |
| 19 | r 406 | 2.83 | 16 |
| 20 | ritlecitinib | 2.77 | 15 |
| 21 | kw 2449 | 2.64 | 13 |
| 22 | zanubrutinib | 2.56 | 12 |
| 23 | tirabrutinib | 1.95 | 6 |
| 24 | Afatinib | 0.69 | 1 |
| 25 | Axitinib | 0.69 | 1 |
| 26 | Crizotinib | 0.69 | 1 |
| 27 | Dasatinib | 0.69 | 1 |
About TXK as a Drug Target
TXK (TXK tyrosine kinase) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 27 compounds with documented TXK interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
TXK inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.